**Charity number: 1184024**
## **BRITISH INHERITED METABOLIC DISEASES GROUP**
## **UNAUDITED**
**TRUSTEES' REPORT AND FINANCIAL STATEMENTS**
**FOR THE YEAR ENDED 31 DECEMBER 2020**
## **BRITISH INHERITED METABOLIC DISEASES GROUP**
## **CONTENTS**
||Page|
|---|---|
|**Reference and Administrative Details of the Charity, its Trustees and Advisers**|1|
|**Trustees' Report**|2 - 4|
|**Independent Examiner's Report**|5 - 6|
|**Statement of Financial Activities**|7|
|**Balance Sheet**|8|
|**Notes to the Financial Statements**|9 - 15|
**BRITISH INHERITED METABOLIC DISEASES GROUP**
## **REFERENCE AND ADMINISTRATIVE DETAILS OF THE CHARITY, ITS TRUSTEES AND ADVISERS FOR THE YEAR ENDED 31 DECEMBER 2020**
|**Trustees**|R Barski|
|---|---|
||Dr E Murphy|
||Dr M Fullerton|
||R Vara|
||A Cozens|
||B McDonald|
||G Toulson|
||A Bowron|
||J Davison|
||J Raiman|
||L Aitkenhead|
||M Barr|
||R Skeath|
||R Gould|
||S Hulley|
||S Forshaw-Hulme|
||B O'Reilly|
||C Dawson (appointed 12 November 2020)|
||F Adrees (appointed 12 November 2020)|
||S Adam (appointed 12 November 2020)|
|**Charity registered**
**number**
1184024
**Principal office**
Hewitsons
Shakespeare House
Cambridge
CB5 8EP
**Accountants**
Peters Elworthy & Moore
Chartered Accountants
Salisbury House
Station Road
Cambridge
CB1 2LA||
Page 1
**BRITISH INHERITED METABOLIC DISEASES GROUP**
## **TRUSTEES' REPORT FOR THE YEAR ENDED 31 DECEMBER 2020**
The Trustees present their annual report together with the financial statements of the Charity for the year 1 January 2020 to 31 December 2020.
## **Objectives and activities**
## **a. Policies and objectives**
To relieve persons suffering from inherited metabolic disease by advancing the education of persons involved in the care and treatment of such persons and to promote research into the treatment and diagnosis of inherited metabolic disease.
The British Inherited Metabolic Disease Group (BIMDG) provides education through meetings and provision of relevant documentation such as meeting reports, care and investigative guidelines available on the website (www.bimdg.org.uk) and a twice yearly News Bulletin.
## **b. Main activities undertaken to further the Charity's purposes for the public benefit**
The main activities undertaken by the charity is to relieve persons suffering from inherited metabolic disease by advancing the education of persons involved in the care and treatment of such persons.
The charity has complied with their duty to have due regard to the commission's public benefit guidance when exercising any powers or duties to which the guidance is relevant.
## **Achievements and performance**
## **a. Main achievements of the Charity**
The 2020 AGM did not take place because of the restrictions in place, as a result of the global pandemic caused by Covid-19. As a consequence the 2020 year saw a dramatic drop in income and expenditure.
The wbsite is continually being updated and improved. The guidelines and protocols available on the wedsite attract most hits on the website.
Education grants are available to help find any healthcare professional BIMDG member to attend relevant meetings or visiting a specialist centre to gain experience in their field.
## **Financial review**
## **a. Going concern**
After making appropriate enquiries, the Trustees have a reasonable expectation that the Charity has adequate resources to continue in operational existence for the foreseeable future. For this reason, they continue to adopt the going concern basis in preparing the financial statements. Further details regarding the adoption of the going concern basis can be found in the accounting policies.
Page 2
## **BRITISH INHERITED METABOLIC DISEASES GROUP**
## **TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2020**
## **b. Reserves policy**
The policy of the charity is to ensure that positive reserves exist in an unrestricted fund to ensure that the objectives of the charity can be satisfied.
The amount held in reserves by the charity at the year end was £64,501 (2019: £61,376) which are unresricted funds.
## **Structure, governance and management**
## **a. Constitution**
British Inherited Metabolic Diseases Group is a registered charity, number 1184024, and is constituted under a Trust deed.
## **b. Methods of appointment or election of Trustees**
The management of the Charity is the responsibility of the Trustees who are elected and co-opted under the terms of the Trust deed.
## **STATEMENT OF TRUSTEES' RESPONSIBILITIES**
The Trustees are responsible for preparing the Trustees' Report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).
The law applicable to charities in England & Wales requires the Trustees to prepare financial statements for each financial year which give a true and fair view of the state of affairs of the Charity and of its incoming resources and application of resources, including its income and expenditure, for that period. In preparing these financial statements, the Trustees are required to:
- select suitable accounting policies and then apply them consistently;
- observe the methods and principles of the Charities SORP (FRS 102);
- make judgments and accounting estimates that are reasonable and prudent;
- state whether applicable UK Accounting Standards (FRS 102) have been followed, subject to any material departures disclosed and explained in the financial statements;
- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the Charity will continue in business.
The Trustees are responsible for keeping adequate accounting records that are sufficient to show and explain the Charity's transactions and disclose with reasonable accuracy at any time the financial position of the Charity and enable them to ensure that the financial statements comply with the Charities Act 2011, the Charity (Accounts and Reports) Regulations 2008 and the provisions of the Trust deed. They are also responsible for safeguarding the assets of the Charity and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
Approved by order of the members of the board of Trustees and signed on their behalf by:
Page 3
## **BRITISH INHERITED METABOLIC DISEASES GROUP**
## **TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2020**
## **R Barski**
Date:
**Dr E Murphy**
25/10/2021
Page 4
## **BRITISH INHERITED METABOLIC DISEASES GROUP**
## **INDEPENDENT EXAMINER'S REPORT FOR THE YEAR ENDED 31 DECEMBER 2020**
## **INDEPENDENT EXAMINER'S REPORT TO THE TRUSTEES OF BRITISH INHERITED METABOLIC DISEASES GROUP ('the Charity')**
I report to the charity Trustees on my examination of the accounts of the Charity for the year ended 31 December 2020.
## **RESPONSIBILITIES AND BASIS OF REPORT**
As the Trustees of the Charity you are responsible for the preparation of the accounts in accordance with the requirements of the Charities Act 2011 ('the 2011 Act').
I report in respect of my examination of the Charity's accounts carried out under section 145 of the 2011 Act and in carrying out my examination I have followed the applicable Directions given by the Charity Commission under section 145(5)(b) of the 2011 Act.
## **INDEPENDENT EXAMINER'S STATEMENT**
Your attention is drawn to the fact that the Charity has prepared the accounts in accordance with Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) in preference to the Accounting and Reporting by Charities: Statement of Recommended Practice issued on 1 April 2005 which is referred to in the extant regulations but has been withdrawn.
I understand that this has been done in order for the accounts to provide a true and fair view in accordance with the Generally Accepted Accounting Practice effective for reporting periods beginning on or after 1 January 2015.
I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe that in any material respect:
1. accounting records were not kept in respect of the Charity as required by section 130 of the 2011 Act; or
2. the accounts do not accord with those records; or
3. the accounts do not comply with the applicable requirements concerning the form and content of accounts set out in the Charities (Accounts and Reports) Regulations 2008 other than any requirement that the accounts give a 'true and fair' view which is not a matter considered as part of an independent examination.
I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.
Page 5
## **BRITISH INHERITED METABOLIC DISEASES GROUP**
## **INDEPENDENT EXAMINER'S REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2020**
This report is made solely to the Charity's Trustees, as a body, in accordance with Part 4 of the Charities (Accounts and Reports) Regulations 2008. My work has been undertaken so that I might state to the Charity's Trustees those matters I am required to state to them in an Independent Examiner's Report and for no other purpose. To the fullest extent permitted by law, I do not accept or assume responsibility to anyone other than the Charity and the Charity's Trustees as a body, for my work or for this report.
Signed:
Dated:
Michael Hewett
ACA DChA
## **PETERS ELWORTHY & MOORE**
Chartered Accountants Salisbury House Station Road
Cambridge
CB1 2LA
Page 6
**BRITISH INHERITED METABOLIC DISEASES GROUP**
## **STATEMENT OF FINANCIAL ACTIVITIES FOR THE YEAR ENDED 31 DECEMBER 2020**
|**Note**
**INCOME FROM:**
Donations and legacies
3
Charitable activities
4
Investments
5
**TOTAL INCOME**
**EXPENDITURE ON:**
Charitable activities
**TOTAL EXPENDITURE**
**NET MOVEMENT IN FUNDS**
**RECONCILIATION OF FUNDS:**
Total funds brought forward
Net movement in funds
**TOTAL FUNDS CARRIED FORWARD**|**Unrestricted**
**funds**
**2020**
**£**
**1,000**
**20,402**
**48**
**21,450**
**18,325**
**18,325**
**3,125**
**61,376**
**3,125**
**64,501**|**Total**
**funds**
**2020**
**£**
**1,000**
**20,402**
**48**
**21,450**
**18,325**
**18,325**
**3,125**
**61,376**
**3,125**
**64,501**|As restated
Total
funds
2019
£
-
89,910
109|
|---|---|---|---|
||||90,019|
||||89,425|
||||89,425|
||||594|
||||60,782
594|
||||61,376|
The Statement of Financial Activities includes all gains and losses recognised in the year.
The notes on pages 9 to 15 form part of these financial statements.
Page 7
## **BRITISH INHERITED METABOLIC DISEASES GROUP**
## **BALANCE SHEET AS AT 31 DECEMBER 2020**
|**Note**
**CURRENT ASSETS**
Debtors
10
Cash at bank and in hand
Creditors: amounts falling due within one
year
11
**NET CURRENT ASSETS**
**TOTAL ASSETS LESS CURRENT**
**LIABILITIES**
**TOTAL NET ASSETS**
**CHARITY FUNDS**
Unrestricted funds
12
**TOTAL FUNDS**|**-**
**67,501**
**67,501**
**(3,000)**|**2020**
**£**
**64,501**
**64,501**
**64,501**
**64,501**
**64,501**|1,731
61,274
63,005
(1,629)|2019
£
61,376|
|---|---|---|---|---|
|||||61,376|
||||||
|||||61,376|
|||||61,376|
||||||
|||||61,376|
The financial statements were approved and authorised for issue by the Trustees and signed on their behalf by:
**R Barski Dr E Murphy** Date: 25/10/21
The notes on pages 9 to 15 form part of these financial statements.
Page 8
**BRITISH INHERITED METABOLIC DISEASES GROUP**
## **NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2020**
## **1. GENERAL INFORMATION**
British Inherited Metabolic Disease Group is a CIO registered in England and Wales.
## **2. ACCOUNTING POLICIES**
## **2.1 BASIS OF PREPARATION OF FINANCIAL STATEMENTS**
The financial statements have been prepared in accordance with the Charities SORP (FRS 102) - Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the Charities Act 2011.
The financial statements have been prepared to give a 'true and fair' view and have departed from the Charities (Accounts and Reports) Regulations 2008 only to the extent required to provide a 'true and fair' view. This departure has involved following the Charities SORP (FRS 102) published in October 2019 rather than the Accounting and Reporting by Charities: Statement of Recommended Practice effective from 1 April 2005 which has since been withdrawn.
British Inherited Metabolic Diseases Group meets the definition of a public benefit entity under FRS 102. Assets and liabilities are initially recognised at historical cost or transaction value unless otherwise stated in the relevant accounting policy.
## **2.2 INCOME**
All income is recognised once the Charity has entitlement to the income, it is probable that the income will be received and the amount of income receivable can be measured reliably.
Grants are included in the Statement of Financial Activities on a receivable basis. The balance of income received for specific purposes but not expended during the period is shown in the relevant funds on the Balance Sheet. Where income is received in advance of entitlement of receipt, its recognition is deferred and included in creditors as deferred income. Where entitlement occurs before income is received, the income is accrued.
## **2.3 EXPENDITURE**
Expenditure is recognised once there is a legal or constructive obligation to transfer economic benefit to a third party, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is classified by activity. The costs of each activity are made up of the total of direct costs and an allocation support costs involved in undertaking each activity. Direct costs attributable to a single activity are allocated directly to that activity. Support costs which are not attributable to a single activity are apportioned between those activities on a basis consistent with the use of resources.
Expenditure on charitable activities is incurred on directly undertaking the activities which further the Charity's objectives, as well as any associated support costs.
Grants payable are charged in the year when the offer is made except in those cases where the offer is conditional, such grants being recognised as expenditure when the conditions attaching are fulfilled. Grants offered subject to conditions which have not been met at the year end are noted as a commitment, but not accrued as expenditure.
Page 9
**BRITISH INHERITED METABOLIC DISEASES GROUP**
## **NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2020**
## **2. ACCOUNTING POLICIES (CONTINUED)**
## **2.3 EXPENDITURE (CONTINUED)**
All expenditure is inclusive of irrecoverable VAT.
## **2.4 INTEREST RECEIVABLE**
Interest on funds held on deposit is included when receivable and the amount can be measured reliably by the Charity; this is normally upon notification of the interest paid or payable by the institution with whom the funds are deposited.
## **2.5 DEBTORS**
Trade and other debtors are recognised at the settlement amount after any trade discount offered. Prepayments are valued at the amount prepaid net of any trade discounts due.
## **2.6 CASH AT BANK AND IN HAND**
Cash at bank and in hand includes cash and short-term highly liquid investments with a short maturity of three months or less from the date of acquisition or opening of the deposit or similar account.
## **2.7 LIABILITIES AND PROVISIONS**
Liabilities are recognised when there is an obligation at the Balance Sheet date as a result of a past event, it is probable that a transfer of economic benefit will be required in settlement, and the amount of the settlement can be estimated reliably.
Liabilities are recognised at the amount that the Charity anticipates it will pay to settle the debt or the amount it has received as advanced payments for the goods or services it must provide.
## **2.8 FUND ACCOUNTING**
General funds are unrestricted funds which are available for use at the discretion of the Trustees in furtherance of the general objectives of the Charity and which have not been designated for other purposes.
## **3. INCOME FROM DONATIONS AND LEGACIES**
||**Unrestricted**|**Total**|Total|
|---|---|---|---|
||**funds**|**funds**|funds|
||**2020**|**2020**|2019|
||**£**|**£**|£|
|Donations|1,000|**1,000**|-|
Page 10
## **BRITISH INHERITED METABOLIC DISEASES GROUP**
## **NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2020**
## **4. INCOME FROM CHARITABLE ACTIVITIES**
|**Unrestricted**
**funds**
**2020**
**£**
Membership subscriptions
9,373
Grants
10,000
Annual Conference
-
Workshops
1,029
20,402
Unrestricted
funds
2019
£
Membership subscriptions
8,741
Annual Conference
51,293
Workshops
29,876
89,910|**Total**
**funds**
**2020**
**£**
**9,373**
**10,000**
**-**
**1,029**|
|---|---|
||**20,402**|
||Total
funds
2019
£
8,741
51,293
29,876|
||89,910|
## **5. INVESTMENT INCOME**
|**Unrestricted**
**funds**
**2020**
**£**
Interest receivable
48
Unrestricted
funds
2019
£
Interest receivable
109|**Total**
**funds**
**2020**
**£**
**48**|
|---|---|
||Total
funds
2019
£
109|
Page 11
## **BRITISH INHERITED METABOLIC DISEASES GROUP**
## **NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2020**
## **6. ANALYSIS OF GRANTS**
|Summer studentships
Summer studentships|**Grants to**
**Individuals**
**2020**
**£**
-
Grants to
Individuals
2019
£
3,200|**Total**
**funds**
**2020**
**£**
**-**|
|---|---|---|
|||Total
funds
2019
£
3,200|
## **7. ANALYSIS OF EXPENDITURE BY ACTIVITIES**
|Medical education
Activities
undertaken
directly
2019
£
Medical education
77,206|**Activities**
**undertaken**
**directly**
**2020**
**£**
9,678
Grant
funding of
activities
2019
£
3,200|**Support**
**costs**
**2020**
**£**
8,647
Support
costs
2019
£
9,019|**Total**
**funds**
**2020**
**£**
**18,325**|
|---|---|---|---|
||||Total
funds
2019
£
89,425|
Page 12
**BRITISH INHERITED METABOLIC DISEASES GROUP**
## **NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2020**
## **7. ANALYSIS OF EXPENDITURE BY ACTIVITIES (CONTINUED)**
## **ANALYSIS OF DIRECT COSTS**
|Annual conference
Bad debts
Workshop costs|**Total**
**funds**
**2020**
**£**
**9,454**
**-**
**224**
**9,678**|Total
funds
2019
£
76,116
1,090
-|
|---|---|---|
|||77,206|
## **ANALYSIS OF SUPPORT COSTS**
|Legal & professional
IT, software and website
Prizes
Travel costs
Other
Committee meeting and travel costs (Governance)
Independent Examination and accountancy (Governance)|**Total**
**funds**
**2020**
**£**
**1,731**
**1,812**
**-**
**257**
**408**
**156**
**4,283**
**8,647**|Total
funds
2019
£
1,051
2,476
100
952
-
1,717
2,723|
|---|---|---|
|||9,019|
## **8. INDEPENDENT EXAMINER'S REMUNERATION**
The independent examiner's remuneration amounts to an independent examiner fee of £900 _(_ 2019 _-_ £1,400 _)_ , and accountancy fees of of £1,600 (2019 - £1,323).
## **9. TRUSTEES' REMUNERATION AND EXPENSES**
During the year, no Trustees received any remuneration or other benefits (2019 - £NIL).
During the year ended 31 December 2020, no Trustee expenses have been incurred, directly or reimbursed, for travel costs (2019 - £832).
Page 13
**BRITISH INHERITED METABOLIC DISEASES GROUP**
## **NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2020**
## **10. DEBTORS**
||**2020**|2019|
|---|---|---|
||**£**|£|
|Prepayments and accrued income|**-**|1,731|
## **11. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR**
|Trade creditors
Accruals and deferred income|**2020**
**£**
**-**
**3,000**
**3,000**|2019
£
189
1,440|
|---|---|---|
||||
|||1,629|
## **12. STATEMENT OF FUNDS STATEMENT OF FUNDS - CURRENT YEAR**
|**UNRESTRICTED FUNDS**
General Funds
**STATEMENT OF FUNDS - PRIOR YEAR**
**UNRESTRICTED FUNDS**
General Funds|**Balance at 1**
**January**
**2020**
**£**
**61,376**
Balance at
22 June
2019
£
60,782|**Income**
**£**
**21,450**
Income
£
90,019|**Expenditure**
**£**
**(18,325)**
Expenditure
£
(89,425)|**Balance at**
**31**
**December**
**2020**
**£**
**64,501**|
|---|---|---|---|---|
|||||Balance at
31
December
2019
£
61,376|
Page 14
## **BRITISH INHERITED METABOLIC DISEASES GROUP**
## **NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2020**
## **13. ANALYSIS OF NET ASSETS BETWEEN FUNDS**
## **ANALYSIS OF NET ASSETS BETWEEN FUNDS - CURRENT PERIOD**
|**Unrestricted**
**funds**
**2020**
**£**
Current assets
67,501
Creditors due within one year
(3,000)
**TOTAL**
64,501|**Total**
**funds**
**2020**
**£**
**67,501**
**(3,000)**
**64,501**|
|---|---|
## **ANALYSIS OF NET ASSETS BETWEEN FUNDS - PRIOR PERIOD**
|Current assets
Creditors due within one year
**TOTAL**|Unrestricted
funds
2019
£
63,005
(1,629)
61,376|Total
funds
2019
£
63,005
(1,629)
61,376|
|---|---|---|
## **14. RELATED PARTY TRANSACTIONS**
The Charity has not entered into any related party transaction during the year, nor are there any outstanding balances owing between related parties and the Charity at 31 December 2020.
Page 15